Valeant Pharma shares ticking lower on AGN / SHPG headlines
For some background: On Apr 22nd AGN confirmed that it has received an unsolicited proposal from Valeant Pharmaceuticals (VRX) to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant common shares and $48.30 in cash per share of common stock of the Company.